These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10908120)

  • 21. Synthesis and biological properties of a novel cephalosporin FR86521 having potent activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Kishi K; Ohki H; Okuda S; Kawabata K; Sakane K; Matsumoto Y; Matsumoto S; Tawara S
    J Antibiot (Tokyo); 1999 Dec; 52(12):1152-5. PubMed ID: 10695681
    [No Abstract]   [Full Text] [Related]  

  • 22. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
    Cho A; Glinka TW; Ludwikow M; Fan AT; Wang M; Hecker SJ
    Bioorg Med Chem Lett; 2001 Jan; 11(2):137-40. PubMed ID: 11206444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.
    Choi KI; Cha JH; Pae AN; Cho YS; Kim Y; Chang MH; Park SH; Park SY; Kim D; Jeong DY; Kim YH; Kong JY; Koh HY
    J Antibiot (Tokyo); 1998 Dec; 51(12):1122-5. PubMed ID: 10048574
    [No Abstract]   [Full Text] [Related]  

  • 26. [Conjugative transfer of glycopeptide and macrolide resistant genes among Enterococci and from Enterococcus faecalis to Staphylococcus aureus].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):21-8. PubMed ID: 12185680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
    Weigel LM; Clewell DB; Gill SR; Clark NC; McDougal LK; Flannagan SE; Kolonay JF; Shetty J; Killgore GE; Tenover FC
    Science; 2003 Nov; 302(5650):1569-71. PubMed ID: 14645850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on 3'-quaternary ammonium cephalosporins--III. Synthesis and antibacterial activity of 3'-(3-aminopyrazolium) cephalosporins.
    Ohki H; Kawabata K; Inamoto Y; Okuda S; Kamimura T; Sakane K
    Bioorg Med Chem; 1997 Mar; 5(3):557-67. PubMed ID: 9113334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of water-soluble cephalosporin derivatives having antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Nomura S; Akagi H; Hiramatsu K
    Chemotherapy; 2001; 47(3):170-6. PubMed ID: 11306785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Cephem-induced vancomycin resistance" observed in phenotypically methicillin-sensitive Staphylococcus aureus isolated from a patient treated with vancomycin and cephems.
    Iwakawa K; Kizu J; Hosaka Y; Yamamoto K
    Jpn J Infect Dis; 2000 Aug; 53(4):167-9. PubMed ID: 11056561
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial mechanisms of rhodomyrtone against important hospital-acquired antibiotic-resistant pathogenic bacteria.
    Leejae S; Taylor PW; Voravuthikunchai SP
    J Med Microbiol; 2013 Jan; 62(Pt 1):78-85. PubMed ID: 23019189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
    Huang V; Brown WJ; Rybak MJ
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.